Our mission is to help people with diabetes to live more normal and longer lives. We are using our proprietary biomimetic glucose binding molecules (GBM) to help enable our partners to make the next generation of continuous glucose monitors (CGM) and glucose-responsive insulins (GRI). Our platform technology is based on over 20 years of cutting-edge research pioneered by Professor Anthony Davis group at the University of Bristol. Inspired by nature's carbohydrate binding molecules, lectins, Professor Davis has become a leader in the field of synthetic lectins. This award-winning chemistry has been published in Science and Nature Chemistry and has laid the foundation for the discovery our Biomimetic GBM platform. info@ziylo.com
Our mission is to help people with diabetes to live more normal and longer lives. We are using our proprietary biomimetic glucose binding molecules (GBM) to help enable our partners to make the next generation of continuous glucose monitors (CGM) and glucose-responsive insulins (GRI). Our platform technology is based on over 20 years of cutting-edge research pioneered by Professor Anthony Davis group at the University of Bristol. Inspired by nature's carbohydrate binding molecules, lectins, Professor Davis has become a leader in the field of synthetic lectins. This award-winning chemistry has been published in Science and Nature Chemistry and has laid the foundation for the discovery our Biomimetic GBM platform. info@ziylo.com
Company Information
- Industry
- Biotechnology
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- Ziylo Ltd Avon Bristol
- City
- Region
- Postal Code
- BS2 0XJ
- Country